Previous close | 9.68 |
Open | 9.77 |
Bid | 9.92 x 100 |
Ask | 10.06 x 400 |
Day's range | 9.28 - 10.24 |
52-week range | 3.84 - 14.75 |
Volume | |
Avg. volume | 496,894 |
Market cap | 259.584M |
Beta (5Y monthly) | 1.12 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
The consensus price target hints at a 122.9% upside potential for Inovio (INO). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q4 2023 Earnings Call Transcript March 6, 2024 Inovio Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-1.12, expectations were $-1.58. Inovio Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, ladies and […]
Q4 2023 Inovio Pharmaceuticals Inc Earnings Call